Genaissance Pharmaceuticals (GNSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genaissance Pharmaceuticals (GNSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (121)	12/17/2002 9:28:53 AM
From: tuck	Read Replies (1) of 183

GNSC made a big fuss about how it was going to make a deal with it technology with pharma. Here's one, but they can't ell us how significant in any numerical sense. It'll be interesting to see the market reaction: >>NEW HAVEN, Conn., Dec. 17 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (Nasdaq: GNSC - News) today announced that it has entered into a pharmacogenomics based agreement with Pharmacia Corporation (NYSE: PHA - News). Genaissance will apply its HAP(TM) Technology to clinical trial samples from Pharmacia. Financial terms of the agreement were not announced. "We are pleased to add Pharmacia to the growing list of pharmaceutical companies that have chosen Genaissance to provide them with the resources for pharmacogenomics based clinical development, further demonstrating the utility of our technology," said Kevin Rakin, President and Chief Executive Officer of Genaissance Pharmaceuticals.<< snip Who else is in that "growing list?" Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next